Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.05 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |